Skip to content
10-Q/A

Quarterly Report

CHINA PHARMACEUTICALS INC

0001013762-11-002530

← back to feed
Filed
Sep 16, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity Q2 2011 · Jun 30, 2011 $49.31M
Stockholders Equity Q2 2011 · Dec 31, 2010 $42.53M
Current Liabilities Q2 2011 · Jun 30, 2011 $3.23M
Current Liabilities Q2 2011 · Dec 31, 2010 $2.24M
Current Assets Q2 2011 · Jun 30, 2011 $31.35M
Current Assets Q2 2011 · Dec 31, 2010 $22.8M
Total Assets Q2 2011 · Jun 30, 2011 $52.54M
Total Assets Q2 2011 · Dec 31, 2010 $44.78M
Shares Diluted Q2 2011 · Jun 30, 2010 67.15M sh
Shares Diluted Q2 2011 · Jun 30, 2010 63.65M sh
Eps Diluted Q2 2011 · Jun 30, 2010 $0.08
Eps Diluted Q2 2011 · Jun 30, 2010 $0.09
Eps Basic Q2 2011 · Jun 30, 2010 $0.08
Eps Basic Q2 2011 · Jun 30, 2010 $0.10
Sga Expense Q2 2011 · Jun 30, 2010 $2.06M
Sga Expense Q2 2011 · Jun 30, 2010 $2.54M
Net Income Q2 2011 · Jun 30, 2010 $5.37M
Operating Income Q2 2011 · Jun 30, 2010 $6.36M
Operating Income Q2 2011 · Jun 30, 2010 $7.57M
Gross Profit Q2 2011 · Jun 30, 2010 $6.08M
Gross Profit Q2 2011 · Jun 30, 2010 $10.31M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $4.37M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $7.19M